IN THIS LIST

S&P High Yield Dividend Aristocrats: A Practitioner's Guide

Making the Case for the S&P Biotechnology Select Industry Index

The Benchmark that Changed the World: Celebrating 20 Years of the Dow Jones Sustainability Indices

Indexing Listed Property Stocks in New Zealand

Sector Primer Series: Consumer Staples

S&P High Yield Dividend Aristocrats: A Practitioner's Guide

Contributor Image
Qing Li

Director, Global Research & Design

Contributor Image
Wenli Bill Hao

Senior Lead, Strategy Indices

INTRODUCTION

In a market environment with low yields and potential interest rate cuts, as seen in the U.S. in 2019, yield-seeking investors may become more interested in equity dividend yield strategies.  Dividend strategies could satisfy investors’ needs in several ways, including higher dividend income, favorable risk-adjusted returns, lower volatility, and more downside protection in bearish market environments.  In this paper, we look at the S&P High Yield Dividend Aristocrats and its characteristics, risk/return profile, and performance attribution.

Two common strategies for dividend investing are high dividend yield and dividend growth.  To capture the premium of a dividend growth strategy, S&P Dow Jones Indices launched the S&P High Yield Dividend Aristocrats in November 2005.  The index is designed to track a basket of stocks from the S&P Composite 1500® that consistently increased their total dividends per share every year for at least 20 consecutive years.[1]  The index universe covers large-, mid-, and small-cap stocks in the U.S. equities market.

The outperformance of the S&P High Yield Dividend Aristocrats has historically been attributed to stock selection rather than sector allocation.  Moreover, the index constituents tend to have the high-quality characteristics of higher operating profitability and more conservative investment growth than the overall market.  From business operations and financial perspectives, high-quality fundamentals form the foundation for sustainable dividend increases.

pdf-icon PD F Download Full Article

Making the Case for the S&P Biotechnology Select Industry Index

Biotechnology has famously improved our quality of life for decades.  It addresses many global health problems, such as infectious and age-related diseases.  Investors can see the potential for significant gains in this sector, due to its potential for new sources of return and diversification of risk.  However, this also comes with the possibility of losses.  The S&PBiotechnology Select Industry Indexs “basket” approach to allocation may provide a solution for those concerned with risk.  It aims to provide diverse exposure to listed biotechnology (biotech) companies across large-, mid-, small-, and micro-cap companies in the U.S.

WHY INVEST IN BIOTECHNOLOGY? 

Based in genetic analysis and engineering, biotech firms primarily engage in the research, development, manufacturing, and, to a lesser extent, marketing of healthcare products based on genetic analysis and engineering.  Biotech has a few important industry-specific characteristics. 

  1. High Investment and Long Waiting Period: It can take as much as a decade to get a new drug from the test tube to the pharmacy shelf.  During this lead time, biotech companies may not generate revenue, and hence are highly dependent on venture capital funds and trading publicly on stock exchanges to fund research and development. 
  2. High Risk: The discovery of new drugs is an expensive, slow, and risky business. Investors need to be aware that the risk of failure of new drugs to reach approval is exceptionally high.  Typically, 85%95% of all new drugs fail to reach approval.[1]  Historically, many biotech companies have experienced serious losses after failing critical research or drug trials.
  3. High Yield: During the research phase, biotech companies tend to be unprofitable. However, once a new breakthrough drug is discovered that proves to be successful in treating diseases, it has the potential to be highly (or exponentially) profitable.  Then, the high yield is protected by adequate IP or copyright to ensure that the company can appropriate its research and design results and reduce the likelihood of imitation by competitors.The rewards and risks of investing in biotech stocks can be significant.  Key factors to consider include the research pipeline, stage of research and clinical trials, secure sources of future financing, regulatory changes, and mergers & acquisitions. 

pdf-icon PD F Download Full Article

The Benchmark that Changed the World: Celebrating 20 Years of the Dow Jones Sustainability Indices

Contributor Image
Mona Naqvi

Global Head of ESG Capital Markets Strategy

S&P Global Sustainable1

INTRODUCTION

The year 1999 gave the world the euro, The Matrix, and the world’s first ever global sustainability benchmark—the Dow Jones Sustainability Index (DJSI).  The product of a landmark collaboration between S&P Dow Jones Indices and SAM1 (now RobecoSAM), the DJSI pioneered sustainable indexing and has shaped corporate sustainability practices ever since.2  To commemorate the 20th anniversary of the DJSI in 2019, we reflect on its origins, its impact on the market, and the possible future of the sustainable investing landscape.  Inclusion in the DJSI is seen as a badge of honor by sustainability champions around the world.  Perhaps no other benchmark has had as profound an impact on the behavior of companies, as they seek to secure a coveted spot in the world-renowned DJSI World each year.  Today, there are over 37,000 sustainable indices available worldwide,3 and with a 60% increase in the number between 2017 and 2018 alone, the industry is rapidly transforming.4  Amid this proliferation of environmental, social, and governance (ESG) benchmarking tools, the DJSI continues to make waves as the evolving global standard for benchmarking corporate sustainability performance, even two decades later.

1700s-1970s: THE ORIGINS OF RESPONSIBLE INVESTING

The notion of responsible investing is practically as old as investing itself. Records date back to the 18th century, when faith-based groups such as the Quakers and the Methodists provided guidance on “sinful” investments to avoid.  To this day, faith-based strategies like Shariah-compliant investing are offered within the broader sustainable investment framework.  However, the modern socially responsible investing (SRI) movement, as we know it, took off in the 1960s and 1970s, for example, with the boycott, divestment, and sanctions against South African companies during the era of apartheid.

Similar measures were adopted during the Vietnam War, culminating in the establishment of the first ethical investment vehicle, the Pax World Balanced Fund, in 1971.[1]  The mutual fund, which avoided investments in the supply chains of the controversial tactical herbicide Agent Orange, offered a channel for values-driven investors seeking to redirect their investments on the basis of pacifist moral principles.  Together, these movements paved the way for a generation of socially conscious investors seeking to affect social and political change, underscoring the ambition of “putting one’s money where one’s mouth is.”

By the 1980s, SRI had become fairly standardized in removing “sin stocks,” such as alcohol, tobacco, weapons, and nuclear energy, from investment portfolios.  Fundamentally about values, SRI is driven by the desire to align one’s investments with one’s beliefs.  But as modern portfolio theory suggests, excluding stocks from the opportunity set reduces potential returns.  While popular with values-driven investors, SRI thus did not gain widespread traction among mainstream investors and was left relegated to those willing to put their beliefs before their returns.  However, the idea that responsible companies are not only morally superior, but are also superior in terms of financial performance was slowly starting to surface.  In the early 1970s, the New York-based journalist Milton Moskowitz published lists of “responsible” and “irresponsible” companies, tracking their performance against the stock market.  In 1973, he wrote in the New York Times, “I do harbor the suspicion that socially insensitive management will eventually make enough mistakes to play havoc with the bottom line.”6  While his thinking underpinned many of the ideas behind corporate social responsibility (CSR), it would remain largely disconnected from the typical investment process until ESG investing later became widespread—in part, due to the launch of the DJSI.

pdf-icon PD F Download Full Article

Indexing Listed Property Stocks in New Zealand

Contributor Image
Michael Orzano

Senior Director, Global Equity Indices

Publicly traded property stocks allow investors to gain exposure to real estate, an illiquid asset class, without sacrificing the liquidity benefits of listed equities.  Property stocks also typically offer higher yields than the broad equity market, may serve as an effective inflation hedge, and may help diversify a portfolio due to their generally low correlations to stocks and bonds.

S&P Dow Jones Indices and NZX Limited jointly launched the S&P/NZX Real Estate Select in November 2015 to serve as an investable benchmark for real estate companies listed on the NZX.  The index includes the largest, most liquid property companies included in the S&P/NZX All Index.  To reduce single stock concentration, the index employs a stock cap of 17.5%, applied semiannually.

Total returns of New Zealand equities, as measured by the S&P/NZX 50Index, and property stocks, as measured by the S&P/NZX Real Estate Select, were relatively similar over the longer term, while volatility was modestly lower for property stocks (see Exhibit 1).  This is somewhat surprising, given that global property stocks have historically had higher volatility than the broader global equity market.  As expected, investmentgrade bond returns were more modest, but were much less volatile than equities and property stocks.

pdf-icon PD F Download Full Article

Sector Primer Series: Consumer Staples

Contributor Image
Louis Bellucci

Senior Director, Index Governance

INTRODUCTION

The Global Industry Classification Standard® (GICS®) assigns companies to business classifications, such as the Consumer Staples sector, according to their principal business activities. The sector is the first level of the fourtiered, hierarchical industry classification system that includes 11 sectors, 24 industry groups, 69 industries, and 158 sub-industries. The GICS assignment system uses quantitative and qualitative factors, including revenues, earnings, and market perception. GICS was developed in 1999 and is jointly managed by S&P Dow Jones Indices and MSCI.

The Consumer Staples sector comprises companies primarily engaged in:

  • Food and staples retailing and distribution, such as owners and operators of hypermarkets, super centers, and pharmacies;
  • Producing food, beverage, and tobacco products; and
  • Manufacturing household and personal products, such as detergents, soaps, diapers, cosmetics, and perfumes.

COMPOSITION

The S&P 500® Consumer Staples includes all companies in the S&P 500 that are assigned to the Consumer Staples sector by GICS.  Created in 1957, the S&P 500 was the first broad U.S. market-cap-weighted stock market index.  Today, it is the basis of many listed and over-the-counter investment instruments.

The Consumer Staples sector is the seventh most heavily weighted of the 11 sectors within the S&P 500.  As of Dec. 31, 2018, the sector represented 7.41% of the S&P 500 (see Exhibit 2). 

There is a lower exposure to Consumer Staples in the mid- and small-cap indices, with the tenth-heaviest sector weight in the S&P MidCap 400® and eighth-heaviest in the S&P SmallCap 600®, at 2.94% and 3.58%, respectively.  Overall, in the S&P Total Market Index, which consists of over

3,800 stocks—including those in the S&P 500, S&P MidCap 400, S&P SmallCap 600, and micro caps—Consumer Staples was the seventh largest sector, with 136 securities and a weight of 6.64%.

Thirty-three companies, with a total float-adjusted market capitalization of USD 1,558.02 billion, comprised the S&P 500 Consumer Staples as of Dec.31, 2018.  The two largest companies in the sector were Procter & Gamble (PG) and Coca-Cola Co (KO), with float-adjusted market caps of USD 229.01 billion and USD 181.39 billion, translating to S&P 500 weights of 1.09% and 0.86%, respectively.  There were no Consumer Staples companies in the top 10 constituents of the S&P 500—Procter & Gamble ranked as the 14th largest.  The mean market cap of S&P 500 Consumer Staples stocks was USD 47.21 billion, the median market cap was USD 22.97 billion, and the minimum market cap was USD 2.96 billion.  The top 10 Consumer Staples holdings made up 73.78% of the sector.  Exhibit 4 shows that the Consumer Staples sector was the third most concentrated in its top 10 components among the 11 GICS sectors.

pdf-icon PD F Download Full Article

Processing ...